Skip to content
healthcare.dev
Get a free key

Irinotecan Hydrochloride

NDC 0143-9702, Irinotecan Hydrochloride, injection, from Hikma Pharmaceuticals USA Inc..

Product NDC
0143-9702
Status
Listed
Labeler
Hikma Pharmaceuticals USA Inc.
Dosage form
INJECTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA091032
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0143-9702 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • IRINOTECAN HYDROCHLORIDE20 mg/mL

Pharmacologic classes

Topoisomerase Inhibitor [EPC]; Topoisomerase Inhibitors [MoA]

Package NDCNDC-11Package
0143-9702-01001439702012 mL in 1 VIAL, GLASS (0143-9702-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/be716692-6b4f-47b6-83d1-01665861626b

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=0143-9702

Use it

Look up 0143-9702 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0143-9702 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0143-9702. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.